HIGHFDA DRUG
Alembic Pharmaceuticals Recalls Fesoterodine Tablets for Impurity Risk
Alembic Pharmaceuticals Limited recalled Fesoterodine Fumarate, Extended-release Tablets after discovering high levels of a harmful impurity. The recall affects approximately 30,000 tablets distributed nationwide. Consumers must stop using the medication immediately and consult their healthcare providers.
FESOTERODINE FUMARATE
Failed Impurities/Degradation